These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8573299)

  • 41. A case of dual chloroquine and halofantrine treatment failure in Zimbabwe.
    Mharakurwa S
    Cent Afr J Med; 1995 Oct; 41(10):327-9. PubMed ID: 8556780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Halofantrine in G-6 PD deficiency.
    Handa R; Wig N; Aggarwal P; Suresh V; Biswas A; Wali JP
    J Assoc Physicians India; 1997 Nov; 45(11):899. PubMed ID: 11229205
    [No Abstract]   [Full Text] [Related]  

  • 44. [The treatment of malaria].
    Kager PA; Zijlmans CW; Boele van Hensbroek M; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1774-8. PubMed ID: 9545726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug alert: halofantrine.
    Wkly Epidemiol Rec; 1993 Sep; 68(37):269-70. PubMed ID: 8217579
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relapse of Plasmodium falciparum malaria after the return from the Ivory Coast. Type R1 halofantrine resistance or successive infections by 2 different strains?].
    Caumes E; Baril L; Danis M; Bricaire F
    Presse Med; 1998 Oct; 27(31):1577-8. PubMed ID: 9819589
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy, safety and acceptability of halofantrine in the treatment of acute Plasmodium falciparum malaria in African children (Gabon).
    Richard-Lenoble D; Kombila M; Martz M; Gendrel D; Gendrel C; Moreno JL; Engohan E; Blanc G; Dupasquier I; Iannascoli F
    J Trop Pediatr; 1992 Feb; 38(1):7-11. PubMed ID: 1573696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Halofantrine (halfan).
    Mossop RT
    Cent Afr J Med; 1993 Oct; 39(10):215-6. PubMed ID: 8020078
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of malaria in children in France].
    Badoual J
    Pediatrie; 1992; 47(5):365-70. PubMed ID: 1331951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical trial with halofantrine on patients with falciparum malaria in Colombia.
    Restrepo M; Botero D; Marquez RE; Boudreau EF; Navaratnam V
    Bull World Health Organ; 1996; 74(6):591-7. PubMed ID: 9060219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Trial of halofantrine in the treatment of malaria attacks by Plasmodium falciparum in Dakar (Senegal)].
    Diallo S; Gaye O; Bah IB; Trape JF; Konate L; Legros C; Dieng T; Faye O
    Bull Soc Pathol Exot; 1991; 84(3):298-303. PubMed ID: 1764759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mislead by 'malaria medication in one's pocket'].
    Lampe AS; Bakker RB; Smith SJ
    Ned Tijdschr Geneeskd; 1993 Aug; 137(33):1674. PubMed ID: 8371800
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy of halofantrine in the treatment of uncomplicated falciparum malaria.
    Mbori-Ngacha DA; Onyango FE; Chunge C; Luta M; Oloo AJ; Muga RO
    East Afr Med J; 1995 Dec; 72(12):796-9. PubMed ID: 8689980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Plasma levels of halofantrine during two therapeutic sessions at a 7 day interval].
    Keundjian A; Touze JE; Bernard J; Bertherat E; Soares JL
    Presse Med; 1995 Jun; 24(22):1047. PubMed ID: 7667235
    [No Abstract]   [Full Text] [Related]  

  • 56. Halofantrine.
    East Afr Med J; 1989 Dec; 66(12):785-6. PubMed ID: 2693066
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro susceptibility of Plasmodium falciparum isolates to halofantrine in the Central Province of Papua New Guinea.
    Hombhanje FW; Kereu RK
    P N G Med J; 1998 Mar; 41(1):30-6. PubMed ID: 10741175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The halofantrine treatment of Plasmodium falciparum malaria. Clinical experience].
    Villota Arrieta J; Barreiro Casal G; García López M; Cilleruelo Ortega MJ; Mellado Peña MJ; Pérez Jurado ML; Martín Fontelos P
    An Esp Pediatr; 1996 Feb; 44(2):117-20. PubMed ID: 8830568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseases.
    Krudsood S; Singhasivanon P; Silachamroon U; Treeprasertsuk S; Kaivipakbanyai W; Chalermrut K; Phophak N; Horton J; Kyle D; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):255-61. PubMed ID: 11556573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection.
    Hau I; Seringe S; Aberrane S; De la Rocque F; Delacourt C; Cohen R; Reinert P; Ovetchkine P
    Eur J Pediatr; 2004 Jan; 163(1):22-4. PubMed ID: 14648211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.